Agenus Inc. (AGEN)
NASDAQ: AGEN · Real-Time Price · USD
2.790
+0.040 (1.45%)
Dec 30, 2024, 12:49 PM EST - Market open
Agenus Employees
Agenus had 389 employees as of December 31, 2023. The number of employees decreased by 144 or -27.02% compared to the previous year.
Employees
389
Change (1Y)
-144
Growth (1Y)
-27.02%
Revenue / Employee
$412,409
Profits / Employee
-$585,751
Market Cap
65.45M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
AGEN News
- 12 days ago - Agenus Announces Five Presentations at ASCO GI Highlighting BOT/BAL Activity Across Colorectal and Gastric Cancers - Business Wire
- 25 days ago - Agenus Announces Strategic Realignment to Focus on Core Programs and Significantly Reduce Costs - Business Wire
- 4 weeks ago - Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment - Business Wire
- 6 weeks ago - Agenus Inc. (AGEN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Agenus Reports Third Quarter 2024 Financial Results and Strategic Advancements in BOT/BAL Development - Business Wire
- 7 weeks ago - Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024 - Business Wire
- 7 weeks ago - Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update - Business Wire
- 2 months ago - November 5 Deadline: Agenus Inc Is Being Sued For Defrauding The Public And Affected Shareholders Are Urged To Contact The Schall Law Firm - Accesswire